Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: A systematic review

Ho SC 1 , Chong HY 2 , Chaiyakunapruk N 3 , Tangiisuran B 1 , Jacob SA 4

Affiliations 

  • 1 School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 USM, Penang Malaysia
  • 2 School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, 47500 Bandar Sunway, Selangor, Malaysia
  • 3 School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, 47500 Bandar Sunway, Selangor, Malaysia; Center of Pharmaceutical Outcomes Research (CPOR), Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand; School of Pharmacy, University of Wisconsin, Madison, USA; School of Population Health, University of Queensland, Brisbane, Australia
  • 4 School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, 47500 Bandar Sunway, Selangor, Malaysia. Electronic address: sabrina.anne@monash.edu
J Affect Disord, 2016 Mar 15;193:1-10.
PMID: 26748881 DOI: 10.1016/j.jad.2015.12.029

Abstract

Medication non-adherence is one of the major challenges in treating patients with depression. This systematic review aims to determine the clinical and economic outcomes of non-adherence in depression.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications